EDGAR Filing Documents for 0001144204-12-034143

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0001144204-12-034143

Filing Date

2012-06-11

Accepted

2012-06-11 12:41:48

Documents

Period of Report

2011-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 2	v315524_20fa.htm	20-F/A	22747
2	LICENSE AGREEMENT	v315524_ex10-53.htm	EX-10.53	154123
	Complete submission text file	0001144204-12-034143.txt		177891

Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140

Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080

XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 20-F/A | Act: 34 | File No.: 000-51310 | Film No.: 12899878
SIC: 2834 Pharmaceutical Preparations